CN104710414A - Preparation method of 2,3-cis-silybin B - Google Patents

Preparation method of 2,3-cis-silybin B Download PDF

Info

Publication number
CN104710414A
CN104710414A CN201310689466.2A CN201310689466A CN104710414A CN 104710414 A CN104710414 A CN 104710414A CN 201310689466 A CN201310689466 A CN 201310689466A CN 104710414 A CN104710414 A CN 104710414A
Authority
CN
China
Prior art keywords
silybin
cis
purity
raw material
half preparative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310689466.2A
Other languages
Chinese (zh)
Inventor
肖红斌
高明哲
赵楠
邹晓伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201310689466.2A priority Critical patent/CN104710414A/en
Publication of CN104710414A publication Critical patent/CN104710414A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)

Abstract

The invention relates to a preparation method of 2,3-cis-silybin B. With silybin B as a raw material, and under an alkaline condition, silybin B is subjected to catalytic conversion into low-content 2,3-cis-silybin B, industrial chromatography enrichment is adopted and combined with semi-preparative chromatographic purification and separation, and thus high-purity 2,3-cis-silybin B is obtained. The 2,3-cis-silybin B is a flavone lignin compound which naturally exists but has low content, a conventional chemical separation method is unable to prepare the high-purity compound, and the method can be used for effective separation to obtain the high-purity 2,3-cis-silybin B.

Description

One prepares the method for the cis-Silybin B of 2,3-
Technical field
The present invention relates to the method that one prepares the cis-Silybin B of 2,3-.
Background technology
Silymarin is the medicinal plants of Compositae Silymarin seed, treatment liver and gall diseases has the history of more than 2000 year, the damage that can prevent chemical toxicant, sitotoxin and medicine etc. from causing liver, promotes hepatocellular regeneration and reparation, is called as " natural hepatoprotective "; In addition, Silymarin, as powerful antioxidant, can be removed the free radical in human body, delay senility.In recent years, its anticancer and tumor prevention effect has demonstrated good potentiality to be exploited.
Silymarin (Silmyarin) is from the seed coat of Silymarin seed, extract the flavone Lignanoids compounds obtained, it is the main active ingredient of Silymarin, comprise 10 kinds of isomeric compounds such as silibinin (Silybin), Isosilybin (Isosilybin), Silychristin (Silychristin) and Silydianin (Silydianin), modern pharmacological research proves that these compounds all have very strong pharmacologically active.The cis-Silybin B of 2,3-(2,3-cis-Silybin B) is a kind of compound in silymarin, and structure is as follows:
This compound content in plant is low, disturb by other isomeric compounds in sepn process, conventional chemical separation method cannot prepare high-purity compound, proves that it is present in Silymarin, be not separated acquisition high-purity compound so far by means of only chromatography-mass spectroscopy method.
Summary of the invention
The present invention relates to the method that one prepares the cis-Silybin B of 2,3-.Take Silybin B as raw material, after carrying out being catalytically conveted to the cis-Silybin B of low levels 2,3-in the basic conditions, adopt industrial chromatography enrichment, in conjunction with half preparative chromatography purifies and separates, obtain the cis-Silybin B of high purity 2,3-.
Concrete steps are as follows:
1) base catalysis of Silybin B transforms
Silybin B raw material mixes with alkali and carries out catalyzed reaction, and reaction terminates rear HCl neutralization reaction liquid, filters 2, the 3-cis-Silybin B conversion products that acquisition content is 1-3%.
2) richness of 2,3-cis-Silybin Bs is amassed
The cis-Silybin B conversion product of 2,3-, through industrial chromatography enrichment, obtains 2, the 3-cis-Silybin B enriched substance that content is 30-70%.
3) purifying of 2,3-cis-Silybin Bs
The cis-Silybin B enriched substance of 2,3-, through half preparative chromatography purifies and separates, obtains 2,3-cis-Silybin B products of more than 95% purity.
Described Silybin B raw material choose Silybin B monomeric compound or mixture.
Base catalysis process alkali used comprises Na 2cO 3, NaHCO 3, ammoniacal liquor, K 2cO 3, KHCO 3one or more.
When using catalyzed by solid base, Ji guest raw material and alkali mass ratio are between 1:0.5 to 1:10, and when using ammonia-catalyzed, silibinin raw material and ammoniacal liquor ratio are between 1:5 to 1:20 (g:ml).
Catalyzed reaction reflux in 40-100% methyl alcohol or ethanolic soln is carried out.
Between HCl neutralization reaction liquid to PH4-7.
Industrial chromatography uses the filling of 10-45um particle diameter C18 filler.
Half preparative chromatography uses 5-10um particle diameter C18 filler.
Industrial chromatography and half preparative chromatography all adopt methanol solution wash-out, and methanol concentration scope is between 50-70%.
Employing the present invention have the following advantages:
The cis-Silybin B of 2,3-is a kind of low levels flavones lignin compound, disturbs in sepn process by other high-content isomeric compounds, is difficult to adopt conventional separation methods to be separated.In the basic conditions, Silybin B can be converted into the cis-Silybin B of 2,3-, and content improves.The reaction conversion ratio that Silybin B alkali is converted into the cis-Silybin B of 2,3-is low, and applicable industry chromatogram carries out Fu Jihou, then through half preparative chromatography purifying, obtains the cis-Silybin B of high purity 2,3-.Compared with being separated with direct post isolation technique, after transforming, the method for preparative separation reduces sample and solvent consumption, shortens process, and method is effective fast, can be separated and obtain this material of high purity.
Accompanying drawing explanation
Fig. 1 is sample thing analysis chart
Wherein A: raw material; B: conversion product; C: enriched substance; D: product; The cis-Silybin B of 1:2,3-.
Embodiment
Now be described in further details the present invention with accompanying drawing, embodiment is only limitted to the present invention is described in conjunction with the embodiments, but not limitation of the invention.
Embodiment 1
10g silibinin mixture (Figure 1A is shown in analysis) and 5g Na2CO3 mixed dissolution are in 40% methyl alcohol, reflux is after 12 hours, and cooling, with HCl neutralization reaction liquid to pH7, filter and obtain 2, the 3-cis-Silybin B conversion products (Figure 1B is shown in analysis) that purity is 3%.Conversion product is separated through industrial chromatography post (190 × 80mm, 15um), 55% methanol-eluted fractions, collect the flow point containing target compound, concentrating under reduced pressure obtains 2, the 3-cis-Silybin B enriched substance (Fig. 1 C is shown in analysis) that purity is 70%, and enriched substance is through half preparative chromatography post (250 × 20mm, 5um) be separated, 60% methanol-eluted fractions, collects the flow point containing target compound, after concentrating under reduced pressure, obtain 2, the 3-cis-Silybin B products (Fig. 1 D is shown in analysis) that purity is 98.4%.
Embodiment 2
10g silibinin mixture and 100g NaHCO3 mixed dissolution are in 100% methyl alcohol, and reflux is after 16 hours, and cooling, with HCl neutralization reaction liquid to pH7, filters and obtain 2, the 3-cis-Silybin B conversion products that purity is 3%.Conversion product is separated through industrial chromatography post (190 × 80mm, 15um), 55% methanol-eluted fractions, collect the flow point containing target compound, concentrating under reduced pressure obtains 2, the 3-cis-Silybin B enriched substance that purity is 30%, and enriched substance is through half preparative chromatography post (250 × 20mm, 10um) be separated, 60% methanol-eluted fractions, collects the flow point containing target compound, after concentrating under reduced pressure, obtain 2, the 3-cis-Silybin B products that purity is 95.5%.
Embodiment 3
0.1g Silybin B monomeric compound and 0.5ml ammoniacal liquor mixed dissolution are in 40% ethanol, and reflux is after 24 hours, and cooling, with HCl neutralization reaction liquid to pH7, filters and obtain 2, the 3-cis-Silybin B conversion products that purity is 1%.Conversion product is separated through industrial chromatography post (240 × 100mm, 45um), 55% methanol-eluted fractions, collect the flow point containing target compound, concentrating under reduced pressure obtains 2, the 3-cis-Silybin B enriched substance that purity is 50%, and enriched substance is through half preparative chromatography post (250 × 10mm, 5um) be separated, 55% methanol-eluted fractions, collects the flow point containing target compound, after concentrating under reduced pressure, obtain 2, the 3-cis-Silybin B products that purity is 97.3%.
Embodiment 4
0.1g Silybin B monomeric compound and 2ml ammoniacal liquor mixed dissolution are in 100% methyl alcohol, and reflux is after 24 hours, and cooling, with HCl neutralization reaction liquid to pH7, filters and obtain 2, the 3-cis-Silybin B conversion products that purity is 3%.Conversion product is separated through industrial chromatography post (200 × 80mm, 45um), 50% methanol-eluted fractions, collect the flow point containing target compound, concentrating under reduced pressure obtains 2, the 3-cis-Silybin B enriched substance that purity is 70%, and enriched substance is through half preparative chromatography post (250 × 20mm, 10um) be separated, 70% methanol-eluted fractions, collects the flow point containing target compound, after concentrating under reduced pressure, obtain 2, the 3-cis-Silybin B products that purity is 98.3%.
Embodiment 5
10g silibinin mixture and 10g K 2cO 3mixed dissolution is in 40% methyl alcohol, and reflux is after 12 hours, and cooling, with HCl neutralization reaction liquid to pH6, filters and obtain 2, the 3-cis-Silybin B conversion products that purity is 3%.Conversion product is separated through industrial chromatography post (190 × 80mm, 15um), 55% methanol-eluted fractions, collect the flow point containing target compound, concentrating under reduced pressure purity is 2, the 3-cis-Silybin B enriched substance of 30%, and enriched substance is through half preparative chromatography post (250 × 20mm, 10um) be separated, 60% methanol-eluted fractions, collects the flow point containing target compound, after concentrating under reduced pressure, obtain 2, the 3-cis-Silybin B products that purity is 98.4%.
Embodiment 6
10g silibinin mixture and 30g KHCO 3mixed dissolution is in 40% methyl alcohol, and reflux is after 36 hours, and cooling, with HCl neutralization reaction liquid to pH4, filters and obtain 2, the 3-cis-Silybin B conversion products that purity is 1%.Conversion product is separated through industrial chromatography post (190 × 75mm, 10um), 55% methanol-eluted fractions, collect the flow point containing target compound, concentrating under reduced pressure obtains 2, the 3-cis-Silybin B enriched substance that purity is 30%, and enriched substance is through half preparative chromatography post (250 × 20mm, 5um) be separated, 50% methanol-eluted fractions, collects the flow point containing target compound, after concentrating under reduced pressure, obtain 2, the 3-cis-Silybin B products that purity is 98.0%.

Claims (9)

1. prepare the method for the cis-Silybin B of 2,3-for one kind, it is characterized in that:
Take Silybin B as raw material, after carrying out being catalytically conveted to the cis-Silybin B of low levels 2,3-in the basic conditions, adopt industrial chromatography enrichment, in conjunction with half preparative chromatography purifies and separates, obtain the cis-Silybin B of high purity 2,3-; Concrete steps are as follows:
1) base catalysis of Silybin B transforms
Silybin B raw material mixes with alkali and carries out catalyzed reaction, and reaction terminates rear HCl neutralization reaction liquid, filters 2, the 3-cis-Silybin B conversion products that acquisition content is 1-3%;
2) richness of 2,3-cis-Silybin Bs is amassed
The cis-Silybin B conversion product of 2,3-, through industrial chromatography enrichment, obtains 2, the 3-cis-Silybin B enriched substance that content is 30-70%;
3) purifying of 2,3-cis-Silybin Bs
The cis-Silybin B enriched substance of 2,3-, through half preparative chromatography purifies and separates, obtains 2,3-cis-Silybin B products of more than 95% purity.
2. method according to claim 1, is characterized in that: described Silybin B raw material choose Silybin B monomeric compound or mixture.
3. method according to claim 1, is characterized in that: base catalysis process alkali used comprises Na 2cO 3, NaHCO 3, ammoniacal liquor, K 2cO 3, KHCO 3one or more.
4. method according to claim 3, is characterized in that: when using catalyzed by solid base, and Ji guest raw material and alkali mass ratio are between 1:0.5 to 1:10, and when using ammonia-catalyzed, silibinin raw material and ammoniacal liquor ratio are between 1:5 to 1:20 (g:ml).
5. method according to claim 1, is characterized in that: catalyzed reaction reflux in 40-100% methyl alcohol or ethanolic soln is carried out.
6. method according to claim 1, is characterized in that: between HCl neutralization reaction liquid to PH4-7.
7. method according to claim 1, is characterized in that: industrial chromatography uses the filling of 10-45um particle diameter C18 filler.
8. method according to claim 1, is characterized in that: half preparative chromatography uses 5-10um particle diameter C18 filler.
9. method according to claim 1, is characterized in that: industrial chromatography and half preparative chromatography all adopt methanol solution wash-out, and methanol concentration scope is between 50-70%.
CN201310689466.2A 2013-12-13 2013-12-13 Preparation method of 2,3-cis-silybin B Pending CN104710414A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310689466.2A CN104710414A (en) 2013-12-13 2013-12-13 Preparation method of 2,3-cis-silybin B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310689466.2A CN104710414A (en) 2013-12-13 2013-12-13 Preparation method of 2,3-cis-silybin B

Publications (1)

Publication Number Publication Date
CN104710414A true CN104710414A (en) 2015-06-17

Family

ID=53410197

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310689466.2A Pending CN104710414A (en) 2013-12-13 2013-12-13 Preparation method of 2,3-cis-silybin B

Country Status (1)

Country Link
CN (1) CN104710414A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302204B6 (en) * 2009-10-21 2010-12-15 Mikrobiologický ústav AV CR, v.v.i. Process for preparing optically pure stereomers of silybin A and silybin B
CN102174041A (en) * 2011-03-24 2011-09-07 江苏中兴药业有限公司 High-purity silymarin and preparation method thereof
CN102478553A (en) * 2010-11-23 2012-05-30 天津天士力制药股份有限公司 Method for detecting silybin
CN102746283A (en) * 2011-04-20 2012-10-24 江苏天士力帝益药业有限公司 Preparation method of high purity silybin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302204B6 (en) * 2009-10-21 2010-12-15 Mikrobiologický ústav AV CR, v.v.i. Process for preparing optically pure stereomers of silybin A and silybin B
CN102478553A (en) * 2010-11-23 2012-05-30 天津天士力制药股份有限公司 Method for detecting silybin
CN102174041A (en) * 2011-03-24 2011-09-07 江苏中兴药业有限公司 High-purity silymarin and preparation method thereof
CN102746283A (en) * 2011-04-20 2012-10-24 江苏天士力帝益药业有限公司 Preparation method of high purity silybin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
付艳辉,等: "水飞蓟宾原料药中微量成分的分离及结构鉴定", 《中药与天然药高峰论坛暨第十二届全国中药和天然药物学术研讨会论文集》 *

Similar Documents

Publication Publication Date Title
CN102976909B (en) Method for extracting and purifying 6-gingerol from ginger
CN102260227B (en) Method for separating paclitaxel and related taxane substances
CN103044503A (en) Method for rapidly and efficiently extracting paeoniflorin and albiflorin
CN103570779A (en) Method for preparing glycyrrhizin by simulated moving bed separation
CN105820147A (en) Preparation method and application of active ingredients of artemisia rupestris
CN103214539A (en) Preparation method of euphol
CN1269831C (en) Method for preparing polygonin and resveratrol
CN103265536A (en) Preparation method of swertisin
CN104231032A (en) Method for separating tripdiolide from Tripterygium Wilfordii Hook F leaves
CN102070683B (en) Method for simultaneously preparing chemical reference substances of parishin, parishin B and parishin C
CN104447910A (en) Method for preparation of loganin from traditional Chinese medicine Cornus officinalis
CN102503996B (en) Method for extracting active constituent from Swertia mussotii plant
CN104710414A (en) Preparation method of 2,3-cis-silybin B
CN104341379A (en) Galangin extraction method
CN104710501A (en) Method for rapidly preparing tripterine chemical reference substance from Common Threewingnut Root extract
CN103880895B (en) A kind of method of utilizing high speed adverse current chromatogram separation and purification to prepare harpagoside and Wyrmslayer glycosides A
CN102702289A (en) Method for purifying three types of flavonoid glycosides from large-leaf poacynum leaves by applying high-speed counter-current chromatography
Song et al. Studies on chemical constituents in herb from Artemisia rupestris
CN104876900A (en) Method for extracting, separating and purifying costunolide and dehydrocostus lactone from elecampane
CN103288785B (en) A kind for the treatment of process of taxol waste residue
CN102093210A (en) Purified preparation method of six ginkgoic acid monomers
CN101297878A (en) Preparation technique of high-content white peony root effective composition
CN104650164A (en) Method for preparing active flavonoid glycoside monomers from pepper leaf
CN102627623B (en) Method for preparing butin from Vernonia anthelmintica fruits
CN103351411B (en) The method for separating and preparing of five kinds of Phenylpropanoid Glycosides glycoside monomeric compounds in Root of Common Lamiophlomis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150617

WD01 Invention patent application deemed withdrawn after publication